22,900 shares in Shire PLC (SHPG) acquired by Havens Advisors LLC



[ad_1]

  Shire logo "title =" Shire logo "clbad =" companylogo "/> Havens Advisors LLC bought a new stake in Shire PLC (NASDAQ: SHPG) in the 2nd quarter, according to its latest filing with the Securities and Exchange La Company purchased 22,900 shares of the biopharmaceutical company, valued at approximately $ 3,866,000, and 2.5% of Havens Advisors LLC's investment portfolio, placing the stock in 15th position. </p>
<p>  Other Major investors recently changed their holdings Raymond James & Associates raised 15.5% of its interest in Shire in the fourth quarter of 2011. Raymond James & Associates now holds 101,051 shares of the biopharmaceutical company valued at $ 15,675,000 after purchased 13,567 additional shares in the last quarter LP acquired a new stake in Shire during the first quarter of approximately $ 113,097,000 Sawtooth Solutions LLC has cquired a new stake in Shire at the 4th estimated value of approximately $ 200,000. Palo Alto Investors LLC lifted its stake in Shire by 4.3% in the fourth quarter. Palo Alto Investors LLC now holds 135,800 shares of the biopharmaceutical company valued at $ 21,065,000 after purchasing an additional 5,600 shares in the last quarter. Finally, Fondren Management LP acquired a new stake in Shire in the fourth quarter valued at approximately $ 1,241,000. Institutional investors and hedge funds own 17.92% of the company's shares. </p>
<p>  Several equity research badysts have recently released stock reports. BidaskClub has updated Shire shares from a "sell" rating to a "sustain" rating in a research note on Tuesday, July 3rd. ValuEngine downgraded Shire's shares from a "hold" note to a "sell" note in a research note on Wednesday, May 2nd. Kepler Capital Markets reiterated a "buy" rating on Shire shares in a research note on Friday, May 11. Royal Bank of Canada reiterated a "buy" rating on Shire shares in a research note on Tuesday, May 8. Finally, BTIG Research reiterated a "buy" note and issued a target price of $ 195.00 on Shire shares in a research note on Sunday, April 29. An badyst evaluated the stock with a sales note, seven gave a reserve note and twelve gave a note to buy the company's stock. The stock currently has an average rating of "Buy" and a consensus target price of $ 201.64 </p>
<p>  SHPG shares traded up $ 0.18 in mid-day Thursday, reaching $ 172.29. 404,090 shares of the company were exchanged for an average volume of 1,375,965. The company has a fast ratio of 0.66, a ratio of 1.14 and a debt ratio of 0.45. The company has a market capitalization of $ 52.60 billion, an outstanding ratio of 11.37, a price / earnings ratio of 1.43 and a beta of 1.28. Shire PLC has a low of $ 123.73 in one year and a high of $ 177.51 in one year. </p>
<p>  Shire (NASDAQ: SHPG) released its quarterly earnings data for the last time on Thursday, April 26. The biopharmaceutical company reported earnings per share (EPS) of $ 3.86 for the quarter, exceeding Thomson's consensus estimate of $ 3.58 by $ 3.58. Shire had a net margin of 28.96% and a return on equity of 13.60%. The company achieved a turnover of $ 3.77 billion during the quarter. In the same quarter last year, the company earned $ 3.63 per share. The company 's revenues grew 5.4% from one year to the next. Research badysts expect Shire PLC to display 15.27 EPS for the current year. </p>
<p>  <strong> About Shire </strong> </p>
<p>  Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes and sells drugs for rare diseases and other conditions specialized all over the world. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology and oncology <!--ViewCount:ArticleHistoryID=21308363&PostDate=2018-7-12&type=f&id=3710292--></p>
<p style=  Institutional Ownership by Quarter for Shire (NASDAQ: SHPG)

Receive news and ratings of Shire Daily – Enter your email address below to receive a concise summary of the latest news and badyst ratings for Shire and related companies with MarketBeat.com FREE Daily Electronic Newsletter.

[ad_2]
Source link